|
Volumn 3, Issue 3, 2004, Pages 251-261
|
Rosacea: where are we now?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ANTIINFLAMMATORY AGENT;
IMMUNOSUPPRESSIVE AGENT;
CLASSIFICATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
INTRADERMAL DRUG ADMINISTRATION;
MULTIMODALITY CANCER THERAPY;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
PHOTOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ROSACEA;
ADMINISTRATION, CUTANEOUS;
ADMINISTRATION, ORAL;
ANTI-BACTERIAL AGENTS;
ANTI-INFLAMMATORY AGENTS;
COMBINED MODALITY THERAPY;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
PHOTOTHERAPY;
RANDOMIZED CONTROLLED TRIALS;
ROSACEA;
|
EID: 3242799757
PISSN: 15459616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (42)
|
References (68)
|